These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6026527)

  • 41. Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum.
    GREINER T; BURCH NR; EDELBERG R
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):208-10. PubMed ID: 13497365
    [No Abstract]   [Full Text] [Related]  

  • 42. Personality change in LSD users.
    Bottrill JH
    J Gen Psychol; 1969 Apr; 80(2d Half):157-61. PubMed ID: 5787006
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of lysergic acid diethylamide (LSD) on temporal recovery (pre-pulse inhibition) of the acoustic startle response in the rat.
    Davis M; Sheard MH
    Pharmacol Biochem Behav; 1975; 3(5):861-8. PubMed ID: 1208627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The variable effects of LSD-25 on the behavior of a heterogeneous group of childhood schizophrenics.
    Simmons JQ; Benor D; Daniel D
    Behav Neuropsychiatry; 1972; 4(1-2):10-6 passim. PubMed ID: 5040232
    [No Abstract]   [Full Text] [Related]  

  • 46. The influence of selective temporal lobe damage on behavior and the response to lysergic acid diethylamide.
    Wood CD
    J La State Med Soc; 1971 Mar; 123(3):95-8. PubMed ID: 5547064
    [No Abstract]   [Full Text] [Related]  

  • 47. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in the liver protein pattern due to lysergic acid diethylamide (LSD).
    MISSERE G; TONINI G; BABBINI M
    Experientia; 1961 Jan; 17():33-4. PubMed ID: 13771306
    [No Abstract]   [Full Text] [Related]  

  • 49. [The effect of lysergic acid diethylamide (LSD-25) on the ERG of cold and warm blooded animals].
    MUELLER-LIMMROTH W; HARTMANN H
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():57-67. PubMed ID: 14476956
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of LSD in time-limited psychotherapy.
    Soskin RA
    J Nerv Ment Dis; 1973 Dec; 157(6):410-9. PubMed ID: 4148471
    [No Abstract]   [Full Text] [Related]  

  • 51. 'Schizophrenia' produced by LSD-25.
    BOLTON WB
    Nurs Times; 1962 Jan; 58():22-4. PubMed ID: 13870860
    [No Abstract]   [Full Text] [Related]  

  • 52. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
    Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
    Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents.
    EVARTS EV
    Ann N Y Acad Sci; 1957 Mar; 66(3):479-95. PubMed ID: 13425237
    [No Abstract]   [Full Text] [Related]  

  • 55. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinico-experimental observations on the changes induced by LSD 25 in epileptic personalities; preliminary notes].
    MASCIANGELO PM
    Riv Sper Freniatr Med Leg Alien Ment; 1959 Jun; 83():750-5. PubMed ID: 14421980
    [No Abstract]   [Full Text] [Related]  

  • 57. Discriminative stimulus properties of lysergic acid diethylamide in the monkey.
    Nielsen EB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR; HEATH RG; MICKLE WA; LLEWELLYN RC
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):623-42. PubMed ID: 13480236
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.
    BELLEVILLE RE; FRASER HF; ISBELL H; LOGAN CR; WIKLER A
    AMA Arch Neurol Psychiatry; 1956 Nov; 76(5):468-78. PubMed ID: 13371962
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of lysergic acid diethylamide (LSD) on cortical sensory evoked potentials in the cat.
    LANGFITT TW; FINNEY LA
    Arch Neurol; 1959 Sep; 1():258-68. PubMed ID: 14413973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.